phosphotyrosine has been researched along with lignans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axelson, M; Bartolazzi, A; del Prete, F; Girnita, A; Girnita, L; Larsson, O | 1 |
| Chen, LH; Demark-Wahnefried, W; Fang, J; Li, H; Lin, X; Sun, Z; Wu, Y | 1 |
2 other study(ies) available for phosphotyrosine and lignans
| Article | Year |
|---|---|
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Dose-Response Relationship, Drug; Humans; Kinetics; Lignans; Models, Molecular; Molecular Conformation; Phosphorylation; Phosphotyrosine; Receptor, IGF Type 1; Tumor Cells, Cultured | 2004 |
Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.
Topics: 4-Butyrolactone; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor I; Lignans; Male; Phosphotyrosine; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Signal Transduction | 2009 |